Observational studyJournal of the American Heart Association2022

Switching to Versus Addition of Incretin-Based Drugs Among Patients With Type 2 Diabetes Taking Sodium-Glucose Cotransporter-2 Inhibitors.

Kristy T K Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.